PRPH (ProPhase Labs) Insider Ownership: 65.17 % (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ProPhase Labs Insider Ownership?

ProPhase Labs PRPH -4.72% Insider Ownership is 65.17 % as of Jul. 29, 2026. The stock has 5 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ProPhase Labs's insider ownership is 65.17%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ProPhase Labs's Institutional Ownership is 0.56%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ProPhase Labs's Float Percentage Of Total Shares Outstanding is 97.04%.

ProPhase Labs Insider Ownership Historical Data

* Premium members only.

The historical data trend for ProPhase Labs's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProPhase Labs Insider Ownership Chart

ProPhase Labs Historical Data

The historical data trend for ProPhase Labs can be seen below:

2025-03-31 2025-04-30 2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-06-30
Insider Ownership 30.22 21.81 21.99 21.99 21.99 21.99 21.99 21.99 19.78 65.17

ProPhase Labs Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 65.17 % mean?
ProPhase Labs (PRPH) has a Insider Ownership of 65.17 % as of Jul. 29, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ProPhase Labs and its competitors.
Is ProPhase Labs' Insider Ownership too high?
ProPhase Labs' current Insider Ownership is 65.17 %.
How does ProPhase Labs' Insider Ownership compare to IDTA and NSTM?
ProPhase Labs' Insider Ownership of 65.17 % can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Diagnostics & Research company?
A good Insider Ownership depends on the Medical Diagnostics & Research industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ProPhase Labs and its competitors. ProPhase Labs's current Insider Ownership is 65.17 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProPhase Labs stock overvalued right now?
Based on GuruFocus' analysis, ProPhase Labs (PRPH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.91, compared to a current price of $0.06 — trading 93.6% below its estimated fair value. The current Insider Ownership is 65.17 %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For ProPhase Labs (PRPH), the current Insider Ownership is 65.17 % as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProPhase Labs Business Description

Address 626 RXR Plaza, 6th Floor, Uniondale, NY, USA, 11556
ProPhase Labs Inc oriented and diversified next generation biotech, genomics and consumer products company that develops and commercializes novel drugs, dietary supplements, and compounds, and human genomic testing. It offer whole genome sequencing and related services. It maintain two operating segments: diagnostic services (which includes its COVID-19 and other diagnostic testing services) and consumer products. It generates majority of revenue from consumer products segment which engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services.